NSE · BLISSGVS
Bliss GVS Pharma Limited (BLISSGVS) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#709
of 5,047 stocks
▲ 151W▲ 21M
Peak #686 · 27 Sep 2026
Bliss GVS Pharma Limited, a midcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, is growing revenue at a solid clip, and posts a modest return on equity.
Market Cap
7,015.65 Cr
P/E Ratio
53.95
P/B Ratio
5.67
ROE
10.94%
ROCE
16.24%
Dividend Yield
0.23%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 313.37 Cr | 285.58 Cr | 256.99 Cr | 218.25 Cr |
| Net Profit | 53.34 Cr | 51.37 Cr | 37.00 Cr | 24.78 Cr |
| EPS | 4.92 | 4.73 | 3.37 | 2.20 |
| Operating Profit | 78.39 Cr | 76.06 Cr | 46.93 Cr | 44.90 Cr |
Shareholding pattern
Promoter
35.01%
Public
64.99%
PUBLIC BREAKDOWN
FII
8.07%
DII
9.47%
MF (within DII)
0.26%
Individuals
30.89%
Mutual fund holdings
₹0.18
Cr total
2
Schemes
2
Fund Houses
₹0.18 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.12 Cr (67.6%)
Bandhan Mutual Fund₹0.06 Cr (32.4%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 08 Jul 2026 | Dividend | Dividend - Re 1 Per Share |
| 18 Feb 2026 | Dividend | Interim Dividend - Re 0.50 Per Share |
| 24 Jul 2025 | Dividend | Annual General Meeting/Dividend - Rs 0.50 Per Share |
| 18 Jul 2024 | Dividend | Annual General Meeting/Dividend - Rs 0.50 Per Share |
| 12 Jul 2023 | Dividend | Annual General Meeting/Dividend - Re 0.50 Per Share |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.